04.08.2016 • NewsElaine BurridgeAlpekPetrochemicals

Alpek in Talks to Buy Petrobras’ PTA/PET Units

Mexican chemical company Alpek is in exclusive talks with Brazil’s Petrobras to buy the Brazilian group’s stakes in Companhia Petroquímica de Pernambuco (Petroquímica Suape) and Companhia Integrada Têxtil de Pernambuco (Citepe). Negotiations are to take place during a 60-day period that started on Jul 28  and may be extended by 30 days.

Petroquímica Suape and Citepe operate an integrated PTA/PET facility in Ipojuca, Pernambuco, Brazil, with a capacity of 700,000 t/y PTA and 450,000 t/y PET. Citepe also operates a 90,000 t/y texturized polyester filament plant at the site. The Mexican company is expected to offer as much as $700 million for the stakes, according to the news agency Reuters.  The petrochemical producers have accumulated losses of $1.7 billion over the past two years, including impairment charges related to Brazil’s largest-ever corruption probe.

A sale would reduce Petrobras’ debt and provide a cash injection into the plants. If both parties reach an agreement, Alpek said the transaction will require further corporate approvals as well as the usual regulatory clearances.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.